Pillai and colleagues in their systematic review titled “role of serum biomarkers in the prediction of outcome in women with threatened miscarriage” found that PAPP-A had a poor and wide sensitivity ranging from 25 to 64% but a high specificity ranging from 88 to 94%. The gene discussed is PAPPA; the disease is spontaneous abortion.